NFKB1 and colon adenocarcinoma: A recent study demonstrated that propionate, similarly to butyrate, may inhibit the activation of NF-κB in colon adenocarcinoma cell line [5] with a consequent reduction of pro-inflammatory factors expression such as TNF-α and IL-1β in colon tissues.